Schiavo G., Rossetto O., Tonello F., Montecucco C.Intracellular targets and metalloprotease activity of tetanus and botulism neurotoxins. Curr Topics Micribiol Immunol1995; 195:161-194.
2.
Dubinsky RM, Gray C., Vetere-Overfield B., Koller WCElectromyographic guidance of botulinum toxin treatment in cervical dystonia . Clin Neuropharmacol1991; 14:262-267.
3.
Comella CL, Buchman AS, Tanner CM, et al. Botulinum toxin injection for spasmodic torticollis: Increased magnitude of benefit with electromyographic assistance. Neurology1992; 42:878-882.
4.
Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders. Neurology1994; 44:2401-2403.
5.
Gelb DJ, Yoshimura DM, Olney RK, et al. Change in pattern of muscle activity following botulinum toxin injections for torticollis. Ann Neurol1991 ; 29:370-376.
6.
Borodic GE, Joseph M., Fay L., et al. Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head Neck1990; 12:392-398.
7.
Cardoso F., Jankovic J.Clinical use of botulinum neurotoxins. Curr Topics Microbiol Immunol1995; 195:123-141.
8.
Speelman JD, Brans Jwm.Cervical dystonia and botulinum treatment: Is electromyographic guidance necessary?Movement Disorders1995; 10:802.
9.
Bertolasi L. , Priori A., Tomelleri G., et al. Botulinum toxin treatment of muscle cramps: A clinical and neurophysiological study. Ann Neurol1997; 41:181-186.
10.
Albanese A. , Bentivoglio AR, Cassetta E., et al. Review article: the use of botulinum toxin in the alimentary tract. Aliment-Pharmacol-Ther1995; 9:599-604.
11.
Jankovic J.Botulinum toxin in movement disorders. Curr Opin Neurol1994; 7(4):358-366.
12.
Pullman SLLimb dystonia: use of butulinum toxin. In: Jankovic J, Hallett M (eds.). Therapeutic use of botulinum toxin. New York: Marcel Dekker, 1994:307-321.